Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004338 · ClinicalTrials.gov registry record · Phase 4
Study of Zinc for Wilson Disease
A Phase 4 study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT00004338 is a Phase 4 study that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 300 participants.
The verdict
NCT00004338, a Phase 4 study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Establish the safety and efficacy of extended maintenance zinc therapy in 200 patients with Wilson disease. II. Establish further the role of zinc in the prophylactic treatment of presymptomatic patients by increasing the current cohort from 80 to at least 100 patients. III. Establish further the role of zinc therapy in pregnant patients with Wilson disease. IV. Establish further the role of zinc therapy in children with Wilson disease.
Interventions
- DRUG zinc acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 1993-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004338
The ClinicalTrials.gov registry entry for NCT00004338 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which zinc acetate is the first listed.
NCT00004338 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004338 about?
NCT00004338 is a clinical study titled "Study of Zinc for Wilson Disease". OBJECTIVES: I. Establish the safety and efficacy of extended maintenance zinc therapy in 200 patients with Wilson disease. II. Establish further the role of zinc in the prophylactic treatment of presymptomatic patients by increasing the current cohort from 80 to at least 100 patients. III. Establi...
What is the current status of trial NCT00004338?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 1993-10.
What interventions are being tested in trial NCT00004338?
The interventions under investigation include: zinc acetate (DRUG).
Who is sponsoring clinical trial NCT00004338?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.